Journal
JOURNAL OF CELLULAR BIOCHEMISTRY
Volume 114, Issue 7, Pages 1457-1463Publisher
WILEY
DOI: 10.1002/jcb.24487
Keywords
HER2; microRNA; miR-199b-5p; BREAST CANCER
Categories
Funding
- National Natural Science Foundation of China [30572200]
Ask authors/readers for more resources
HER2 (ErbB2) has been reported to be overexpressed in 2030% of breast cancer and confers poor survival because of high proliferation and metastasis rates. MicroRNAs are small noncoding RNAs that are responsible for the post-transcriptional regulation of target genes. We found miR-199b-5p inhibited HER2 expression by direct targeting its 3-untranslated region (3UTR) in breast cancer cells. In addition, miR-199b-5p inhibited HER2 downstream signaling by ERK1/2 and AKT pathways in breast cancer cells. Besides, transwell migration, wound healing, and clonogenicity were obviously inhibited by overexpression of miR-199b-5p in HER2-positive breast cancer cells. We also found that miR-199b-5p could enhance the suppression of trastuzumab on cell migration and clonogenicity. These results suggest that miR-199b-5p may have the potential to be a novel important alternative therapeutic target for HER2-positive breast cancer. J. Cell. Biochem. 114: 14571463, 2013. (c) 2013 Wiley Periodicals, Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available